---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-016326"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T02:11:17.768467+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech (FBIO) effects 1-for-15 reverse stock split on Oct 10 to meet Nasdaq $1 bid

## Summary
- Reverse split ratio of 1:15; shares reduce from ~134.1M to ~8.9M.
- Effective at open on October 10, 2023; new CUSIP 34960Q307.
- Stockholders approved split at Oct 9 special meeting: 92.4M for, 3.6M against, 1.0M abstain.
- Purpose: comply with Nasdaq minimum $1.00 bid price continued listing requirement.
- No fractional shares; cash payment in lieu; ticker FBIO unchanged.

## SEC filing metadata
- accession: 0001558370-23-016326
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/0001558370-23-016326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/fbio-20231009x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-016326
- JSON: https://secwatch.observer/filing/0001558370-23-016326.json
- Plain text: https://secwatch.observer/filing/0001558370-23-016326.txt

## Key facts
- Governance Changes
  Fortress Biotech, Inc.: The Company filed a Certificate of Amendment to effect a 1-for-15 reverse stock split of common stock, approved by stockholders and board, effective October 10, 2023 (effective 2023-10-10).
  - Change: charter amendment
  - Effective: 2023-10-10
  source text: On October 9, 2023, Fortress Biotech, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Amendment ”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of Delaware to effect a 1-for-15 reverse stock split (the “ Reverse Stock Split ”) of the Company’s shares of common stock, $0.001 par value (the “ Common Stock ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1429260/000155837023016326/0001558370-23-016326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.